• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Finland·Healthcare·PIHLIS.HE
Share

Pihlajalinna Oyj Stocks

€ 10.76Last Updated 12.06.2026

Issuer Rating

5/7
Performance

Strong

Risk

Moderate

Recommendation

Hold

Market Cap

€ 279.75M

€ 10.76
Key Takeaways

Risk factor

Poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Established in 2001 and headquartered in Tampere, Finland, Pihlajalinna Oyj is a leading Finnish provider of comprehensive social and healthcare services. The company caters to a diverse clientele across Finland, including private individuals, corporations, insurance companies, municipalities, and regional hospital districts. Its extensive range of offerings covers primary care from general practitioners, specialized medical consultations, and occupational health services for businesses. Pihlajalinna also provides outsourcing solutions for social and healthcare functions, operates fitness centers, and delivers remote consultation and responsible doctor services. Additionally, the company is involved in residential care and healthcare staffing. The specialized medical fields covered by Pihlajalinna are vast, encompassing geriatrics, gynecology, adult and youth psychiatry, neurology, radiology, and various sub-specialties within internal medicine (including cardiology and pulmonary diseases). Other areas of expertise include orthopedics, general and plastic surgery, urology, dialysis, and ear, nose, and throat (ENT) care. Complementing these are essential services such as emergency and on-call medical assistance, dental care, substance abuse clinics, and family service centers.

Company Valuation

Greatly undervalued
7/7

From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, undervalued o

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of PIHLIS.HE is 13 and suggests 26% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

13.06.2026 03:02

Microsoft is considering spinning off Xbox into a separate company - The Information

13.06.2026 01:40

Hope for peace with Iran and SpaceX lifted spirits: stocks rose for second straight day

13.06.2026 01:05

SpaceX shares rose in value by 19% on the first day of trading. Is it worth buying them?

13.06.2026 01:04

SpaceX shares slowed before closing in first trading since record IPO

13.06.2026 00:44

Retail investors bought $15 billion worth of SpaceX stock. Demand was at least 6 times that amount

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026